Skip to main content
NCBI home page
Proceedings of the Royal Society of Medicine logoLink to Proceedings of the Royal Society of Medicine
. 1969 Nov;62(11 Pt 1):1102–1107. doi: 10.1177/003591576906211P116

Amines and Abnormal Mood

W G Dewhurst
PMCID: PMC1810643  PMID: 5356863

Full text

PDF
1102

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ASHCROFT G. W., SHARMAN D. F. 5-Hydroxyindoles in human cerebrospinal fluids. Nature. 1960 Jun 25;186:1050–1051. doi: 10.1038/1861050a0. [DOI] [PubMed] [Google Scholar]
  2. BONNYCASTLE D. D., GIARMAN N. J., PAASONEN M. K. Anticonvulsant compounds and 5-hydroxytryptamine in rat brain. Br J Pharmacol Chemother. 1957 Jun;12(2):228–231. doi: 10.1111/j.1476-5381.1957.tb00125.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bourne H. R., Bunney W. E., Jr, Colburn R. W., Davis J. M., Davis J. N., Shaw D. M., Coppen A. J. Noradrenaline, 5-hydroxytryptamine, and 5-hydroxyindoleacetic acid in hindbrains of suicidal patients. Lancet. 1968 Oct 12;2(7572):805–808. doi: 10.1016/s0140-6736(68)92459-8. [DOI] [PubMed] [Google Scholar]
  4. Bunney W. E., Jr, Davis J. M., Weil-Malherbe H., Smith E. R. Biochemical changes in psychotic depression. High norepinephrine levels in psychotic vs neurotic depression. Arch Gen Psychiatry. 1967 Apr;16(4):448–460. doi: 10.1001/archpsyc.1967.01730220060010. [DOI] [PubMed] [Google Scholar]
  5. CARLSSON A., LINDQVIST M., MAGNUSSON T. 3,4-Dihydroxyphenylalanine and 5-hydroxytryptophan as reserpine antagonists. Nature. 1957 Nov 30;180(4596):1200–1200. doi: 10.1038/1801200a0. [DOI] [PubMed] [Google Scholar]
  6. COPPEN A., SHAW D. M., MALLESON A. CHANGES IN 5-HYDROXYTRYPTOPHAN METABOLISM IN DEPRESSION. Br J Psychiatry. 1965 Jan;111:105–107. doi: 10.1192/bjp.111.470.105. [DOI] [PubMed] [Google Scholar]
  7. COSTA E. The role of serotonin in neurobiology. Int Rev Neurobiol. 1960;2:175–227. doi: 10.1016/s0074-7742(08)60123-3. [DOI] [PubMed] [Google Scholar]
  8. Coppen A., Shaw D. M., Malleson A., Eccleston E., Gundy G. Tryptamine metabolism in depression. Br J Psychiatry. 1965 Oct;111(479):993–998. doi: 10.1192/bjp.111.479.993. [DOI] [PubMed] [Google Scholar]
  9. Coppen A. The biochemistry of affective disorders. Br J Psychiatry. 1967 Nov;113(504):1237–1264. doi: 10.1192/bjp.113.504.1237. [DOI] [PubMed] [Google Scholar]
  10. DEGKWITZ R., FROWEIN R., KULENKAMPFF C., MOHS U. [On the effects of L-dopa in man and their modification by reserpine, chlorpromazine, iproniazid and vitamin B6]. Klin Wochenschr. 1960 Feb 1;38:120–123. doi: 10.1007/BF02189076. [DOI] [PubMed] [Google Scholar]
  11. DEWHURST W. G., PARE C. M. A clinical and biochemical study of monoamine oxidase inhibition in depressed patients. I. A clinical trial of Nialamide. J Ment Sci. 1961 Mar;107:239–243. doi: 10.1192/bjp.107.447.239. [DOI] [PubMed] [Google Scholar]
  12. Dencker S. J., Malm U., Roos B. E., Werdinius B. Acid monoamine metabolites of cerebrospinal fluid in mental depression and mania. J Neurochem. 1966 Dec;13(12):1545–1548. doi: 10.1111/j.1471-4159.1966.tb04320.x. [DOI] [PubMed] [Google Scholar]
  13. ELMADJIAN F., HOPE J. M., LAMSON E. T. Excretion of epinephrine and norepinephrine in various emotional states. J Clin Endocrinol Metab. 1957 May;17(5):608–620. doi: 10.1210/jcem-17-5-608. [DOI] [PubMed] [Google Scholar]
  14. FELDSTEIN A., HOAGLAND H., WONG K. K., OKTEM M. R., FREEMAN H. MAO ACTIVITY IN RELATION TO DEPRESSION. Am J Psychiatry. 1964 Jun;120:1192–1194. doi: 10.1176/ajp.120.12.1192. [DOI] [PubMed] [Google Scholar]
  15. FISCHER E., LUDMER R. L., KRUGLIKOFF S. R. EFFECT OF METHYLAMPHETAMINE ON THE PSYCHOMOTOR DEPRESSION PRODUCED BY ADRENALINE IN MICE. Nature. 1964 Nov 14;204:695–696. doi: 10.1038/204695a0. [DOI] [PubMed] [Google Scholar]
  16. FOTHERBY K., ASHCROFT G. W., AFFLECT J. W., FORREST A. D. Studies on sodium transfer and 5-hydroxyindoles in depressive illness. J Neurol Neurosurg Psychiatry. 1963 Feb;26:71–73. doi: 10.1136/jnnp.26.1.71. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Fog R. L., Randrup A., Pakkenberg H. Neuroleptic action of quaternary chlorpromazine and related drugs injected into various brain areas in rats. Psychopharmacologia. 1968;12(5):428–432. doi: 10.1007/BF00401348. [DOI] [PubMed] [Google Scholar]
  18. GELDER M. G., VANE J. R. Interaction of the effects of tyramine, amphetamine and reserprine in man. Psychopharmacologia. 1962 Oct 5;3:231–241. doi: 10.1007/BF00411364. [DOI] [PubMed] [Google Scholar]
  19. GLOWINSKI J., AXELROD J. INHIBITION OF UPTAKE OF TRITIATED-NORADRENALINE IN THE INTACT RAT BRAIN BY IMIPRAMINE AND STRUCTURALLY RELATED COMPOUNDS. Nature. 1964 Dec 26;204:1318–1319. doi: 10.1038/2041318a0. [DOI] [PubMed] [Google Scholar]
  20. GLOWINSKI J., KOPIN I. J., AXELROD J. METABOLISM OF (H3)NOREPINEPHRINE IN THE RAT BRAIN. J Neurochem. 1965 Jan;12:25–30. doi: 10.1111/j.1471-4159.1965.tb10247.x. [DOI] [PubMed] [Google Scholar]
  21. GYERMEK L., POSSEMATO C. Potentiation of 5-hydroxytryptamine by imipramine. Med Exp Int J Exp Med. 1960;3:225–229. doi: 10.1159/000134954. [DOI] [PubMed] [Google Scholar]
  22. HARRIS T. H. Depression induced by Rauwolfia compounds. Am J Psychiatry. 1957 Apr;113(10):950–950. doi: 10.1176/ajp.113.10.950. [DOI] [PubMed] [Google Scholar]
  23. HESS S. M., REDFIELD B. G., UDENFRIEND S. The effect of monoamine oxidase inhibitors and tryptophan on the tryptamine content of animal tissues and urine. J Pharmacol Exp Ther. 1959 Nov;127:178–181. [PubMed] [Google Scholar]
  24. Haskovec L., Rysánek K. The action of reserpine in imipramine-resistant depressive patients. Clinical and biochemical study. Psychopharmacologia. 1967;11(1):18–30. doi: 10.1007/BF00401505. [DOI] [PubMed] [Google Scholar]
  25. Haskovec L., Soucek K. Trial of methysergide in mania. Nature. 1968 Aug 3;219(5153):507–508. doi: 10.1038/219507a0. [DOI] [PubMed] [Google Scholar]
  26. KLERMAN G. L., SCHILDKRAUT J. J., HASENBUSH L. L., GREENBLATT M., FRIEND D. G. CLINICAL EXPERIENCE WITH DIHYDROXYPHENYLALANINE (DOPA) IN DEPRESSION. J Psychiatr Res. 1963 Dec;1:289–297. doi: 10.1016/0022-3956(63)90004-9. [DOI] [PubMed] [Google Scholar]
  27. KLINE N. S., SACKS W. Relief of depression within one day using an M.A.O. inhibitor and intravenous 5-HTP. Am J Psychiatry. 1963 Sep;120:274–275. doi: 10.1176/ajp.120.3.274. [DOI] [PubMed] [Google Scholar]
  28. KLINE N. S., SACKS W., SIMPSON G. M. FURTHER STUDIES ON: ONE DAY TREATMENT OF DEPRESSION WITH 5-HTP. Am J Psychiatry. 1964 Oct;121:379–381. doi: 10.1176/ajp.121.4.379. [DOI] [PubMed] [Google Scholar]
  29. KRNJEVIC K., PHILLIS J. W. Actions of certain amines on cerebral cortical neurones. Br J Pharmacol Chemother. 1963 Jun;20:471–490. doi: 10.1111/j.1476-5381.1963.tb01484.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. PARE C. M., SANDLER M. A clinical and biochemical study of a trial of iproniazid in the treatment of depression. J Neurol Neurosurg Psychiatry. 1959 Aug;22:247–251. doi: 10.1136/jnnp.22.3.247. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. PLETSCHER A., SHORE P. A., BRODIE B. B. Serotonin release as a possible mechanism of reserpine action. Science. 1955 Aug 26;122(3165):374–375. doi: 10.1126/science.122.3165.374. [DOI] [PubMed] [Google Scholar]
  32. ROTHBALLER A. B. The effects of catecholamines on the central nervous system. Pharmacol Rev. 1959 Jun;11(2 Pt 2):494–547. [PubMed] [Google Scholar]
  33. SCHACHTER S., SINGER J. E. Cognitive, social, and physiological determinants of emotional state. Psychol Rev. 1962 Sep;69:379–399. doi: 10.1037/h0046234. [DOI] [PubMed] [Google Scholar]
  34. SCHANBERG S. M. A study of the transport of 5-hydroxytryptophan and 5-hydroxytryptamine (serotonin) into brain. J Pharmacol Exp Ther. 1963 Feb;139:191–200. [PubMed] [Google Scholar]
  35. SMITH B., PROCKOP D. J. Central-nervous-system effects of ingestin of L-tryptophan by normal subjects. N Engl J Med. 1962 Dec 27;267:1338–1341. doi: 10.1056/NEJM196212272672603. [DOI] [PubMed] [Google Scholar]
  36. SPECTOR S., SJOERDSMA A., UDENFRIEND S. BLOCKADE OF ENDOGENOUS NOREPINEPHRINE SYNTHESIS BY ALPHA-METHYL-TYROSINE, AN INHIBITOR OF TYROSINE HYDROXYLASE. J Pharmacol Exp Ther. 1965 Jan;147:86–95. [PubMed] [Google Scholar]
  37. STROM-OLSEN R., WEIL-MALHERBE H. Humoral changes in manic-depressive psychosis with particular reference to the excretion of catechol amines in urine. J Ment Sci. 1958 Jul;104(436):696–704. doi: 10.1192/bjp.104.436.696. [DOI] [PubMed] [Google Scholar]
  38. Schildkraut J. J., Green R., Gordon E. K., Durell J. Normetanephrine excretion and affective state in depressed patients treated with imipramine. Am J Psychiatry. 1966 Dec;123(6):690–700. doi: 10.1176/ajp.123.6.690. [DOI] [PubMed] [Google Scholar]
  39. Schildkraut J. J., Kety S. S. Biogenic amines and emotion. Science. 1967 Apr 7;156(3771):21–37. doi: 10.1126/science.156.3771.21. [DOI] [PubMed] [Google Scholar]
  40. Shaw D. M., Camps F. E., Eccleston E. G. 5-Hydroxytryptamine in the hind-brain of depressive suicides. Br J Psychiatry. 1967 Dec;113(505):1407–1411. doi: 10.1192/bjp.113.505.1407. [DOI] [PubMed] [Google Scholar]
  41. TURNER W. J., MERLIS S. A CLINICAL TRIAL OF PARGYLINE AND DOPA IN PSYCHOTIC SUBJECTS. Dis Nerv Syst. 1964 Sep;25:538–541. [PubMed] [Google Scholar]
  42. TWAROG B. M., PAGE I. H. Serotonin content of some mammalian tissues and urine and a method for its determination. Am J Physiol. 1953 Oct;175(1):157–161. doi: 10.1152/ajplegacy.1953.175.1.157. [DOI] [PubMed] [Google Scholar]
  43. VON EULER U. S., LUNDBERG U. Effect of flying on the epinephrine excretion in air force personnel. J Appl Physiol. 1954 Mar;6(9):551–555. doi: 10.1152/jappl.1954.6.9.551. [DOI] [PubMed] [Google Scholar]

Articles from Proceedings of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press

RESOURCES